Why GLP-1 medications cause nausea
GLP-1 receptor agonists slow gastric emptying — food stays in the stomach longer, which produces the satiety effect that drives weight loss. According to a review indexed in NIH PMC on GLP-1 and gastric emptying, the same delay is what produces the queasy, "still full from yesterday" sensation that most patients describe as nausea, especially in the first 24–72 hours after a dose.
Timing of symptoms
Symptoms typically peak in the first 1–3 days after each weekly injection, then taper. With every dose escalation the cycle resets at a higher intensity. A PubMed systematic review of GI adverse events with GLP-1 receptor agonists confirms holding a dose for an additional 2–4 weeks before escalating again is the single most effective lever for reducing peak nausea.
Practical management
Eat smaller meals more frequently — five or six 200-calorie meals tend to be much better tolerated than three 500-calorie meals. Avoid high-fat foods and alcohol on dose days. Mayo Clinic's overview of GLP-1 side effects recommends staying hydrated; dehydration amplifies the queasy feeling and creates a self-reinforcing cycle.
When to call your prescriber
Vomiting that prevents fluid intake for more than 24 hours, abdominal pain that radiates to the back, or any new symptom that worsens rather than improves over a week — these warrant prompt evaluation rather than continued tolerance.